EFFECTS OF CORTISONE ON HUMAN PLACENTA METABOLISM INVITRO

被引:2
|
作者
GORDON, EE
VILLEE, CA
机构
关键词
D O I
10.1016/0003-9861(54)90478-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:306 / 307
页数:2
相关论文
共 50 条
  • [41] DESULFURATION OF THE INSECTICIDE PARATHION BY HUMAN PLACENTA INVITRO
    SULTATOS, LG
    GAGLIARDI, CL
    BIOCHEMICAL PHARMACOLOGY, 1990, 39 (04) : 799 - 801
  • [42] EXTRACELLULAR VOLUME OF THE HUMAN-PLACENTA INVITRO
    LEAR, GH
    BARKER, G
    SIBLEY, CP
    BOYD, RDH
    BIOLOGY OF THE NEONATE, 1989, 55 (03): : 143 - 150
  • [43] TRANSFER OF SALBUTAMOL IN THE HUMAN-PLACENTA INVITRO
    NANDAKUMARAN, M
    GARDEY, CL
    CHALLIER, JC
    RICHARD, MO
    PANIGEL, M
    OLIVE, G
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1981, 3 (02): : 88 - 98
  • [44] ALANINE PRODUCTION FROM THE INVITRO HUMAN PLACENTA
    PHILIPPS, AF
    DUBIN, JW
    MATTY, PJ
    PEDIATRIC RESEARCH, 1981, 15 (04) : 487 - 487
  • [45] NUCLEIC ACID METABOLISM OF HUMAN PLACENTA
    HAYASHI, TT
    BALDRIDGE, RC
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1963, 6 (01): : 57 - 61
  • [46] The carbohydrate metabolism of human placenta.
    Felix, K
    von Oettingen, K
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1925, 144 (3/6): : 190 - 195
  • [47] Drug Transfer and Metabolism by the Human Placenta
    Michael R. Syme
    James W. Paxton
    Jeffrey A. Keelan
    Clinical Pharmacokinetics, 2004, 43 : 487 - 514
  • [48] Metabolism of glibenclamide (glyburide) by human placenta
    Jain, S
    Zharikova, O
    Ravindran, S
    Nanovskaya, T
    Hankins, GDV
    Ahmed, MS
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : S91 - S91
  • [49] Oxygen metabolism in human placenta mitochondria
    J. Bustamante
    R. Ramírez-Vélez
    A. Czerniczyniec
    D. Cicerchia
    A. C. Aguilar de Plata
    S. Lores-Arnaiz
    Journal of Bioenergetics and Biomembranes, 2014, 46 : 459 - 469
  • [50] Drug transfer and metabolism by the human placenta
    Syme, MR
    Paxton, JW
    Keelan, JA
    CLINICAL PHARMACOKINETICS, 2004, 43 (08) : 487 - 514